OMERS Administration Corp’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300,800
Closed -$1.22M 903
2025
Q1
$1.22M Buy
300,800
+183,900
+157% +$613K 0.01% 520
2024
Q4
$374K Buy
+116,900
New +$396K ﹤0.01% 769

OMERS Administration Corp's CKPT Position: Q2 2025 in Review

OMERS Administration Corp sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 300,800 shares — an estimated $1.22M sold.

OMERS Administration Corp first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $1.22M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

  • OMERS Administration Corp reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 300,800 Checkpoint Therapeutics shares in Q2 2025, an estimated $1.22M.
  • OMERS Administration Corp first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Checkpoint Therapeutics position peaked at $1.22M in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.